Massively accelerated image processing supports development of novel treatments for neurological conditions
This Sunday more than 50 Cambridge Consultants staff will take to the streets of Cambridge in the Saucony Cambridge Half Marathon.
Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced the successful close of its Series B funding.
The Saranas Early Bird™ Bleed Monitoring System becomes the first and only device on the market for early bleed detection during endovascular procedures.
Cambridge Consultants wins two prestigious iF DESIGN AWARDS for Aalto, an injection device for rheumatoid arthritis patients, and Alma a smart cooling case for injectable fertility drugs.
Kytopen engages Cambridge Consultants to co-develop alpha Flowfect™ System
Cambridge Consultants and Waymap have created a unique smartphone service that helps visually impaired people to navigate through complex indoor spaces, such as public transport hubs.
A new interactive bar experience from Cambridge Consultants is announced today bridging the digital and physical worlds.
VeriTherm is a new and fast approach to verifying the thermal performance of buildings prior to occupation.
In partnership with One Young World, Cambridge Consultants is supporting young people applying technology to address the United Nations Sustainable Development Goals
BacillAi is a concept system using AI and low-cost hardware to improve treatment monitoring of TB in resource-limited countries, part of our mission to move AI beyond the hype, addressing practical, global challenges.